NDC 50742-376 – Buprenorphine

Buprenorphine 20 ug/h · Patch, Extended Release · Transdermal

Human Prescription Drug DEA schedule CIII

Product NDC50742-376

Product details

Brand name
Buprenorphine
Generic name
Buprenorphine
Labeler
INGENUS PHARMACEUTICALS, LLC
Dosage form
Patch, Extended Release
Route
Transdermal
Marketing category
ANDA · ANDA210272
Marketed since
November 1, 2023
Listing expires
December 31, 2027
Pharmacologic class
Partial Opioid Agonist

Active ingredients

Uses, dosage, side effects and warnings for Buprenorphine →

Package NDC codes (1)

Package NDCDescriptionSince
50742-376-044 POUCH in 1 CARTON (50742-376-04) / 1 PATCH in 1 POUCH / 168 h in 1 PATCHNov 1, 2023

Other Buprenorphine products